PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced it will present on its next-generation DNA medicine technology for rare diseases at the upcoming Orphan Drug Summit in Boston, Massachusetts.
The presentation, titled “DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease,” is scheduled for July 16 from 4:30 to 4:55 p.m. ET.
INOVIO’s session will highlight its DNA-encoded monoclonal antibody (DMAb) technology and its potential to address rare diseases, an area often lacking effective treatments.
The Orphan Drug Summit brings together industry leaders and innovators focused on advancing therapies for rare disease patients.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.